HIV/AIDS

MD Magazine® and Contagion™ expand Strategic Alliance Partnership with American Academy of HIV Medicine.

The American Academy of HIV Medicine in Washington, DC. has signed on as a "strategic partner" with MD Magazine and its sister publication Contagion.

Getting tested for HIV can be accompanied with the feeling of judgement. So if healthcare officials want to encourage testing, they might want to rely on peer-referral.

Why do many men decline to use the pre-exposure prophylaxis (PrEP) (Truvada) to reduce their high risk of the human immunodeficiency virus (HIV) infection? A new survey study out of the United Kingdom may have some of the answers.

The United Kingdom and Ireland have reached a record low rate of perinatal HIV transmissions.

Researchers have been exploring the “shock and kill” method to get rid of the virus for good, but a new study warns that the strategy could make things even worse.

As December 1 marks World AIDS Day, researchers report on the latest prevention and diagnosis strategies as well as a threat in the quest to eradicate the disease.

Although antiretroviral therapy is effective in suppressing HIV-1 replication, it does not eradicate the virus and it requires lifelong adherence to the therapy. Authors of a new study say that bNAbs may be the key.

With sexual activity being a leading cause of HIV infection, researchers from the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona, Spain aimed to find how dolutegravir impacts the risk of HIV transmission.

Healthcare workers might be expected to have the facts on HIV transmission rates. A study showed that at a Kansas tertiary care hospital, more than a quarter of workers who answered a survey harbored misconceptions.

Depression is associated with cardiac risk factors in HIV-positive people. But does depression make these HIV patients more likely to die?

What happens to patients who walk away from care at their HIV clinic? A Pennsylvania team found which ones were most likely to die.

Combining the common cold virus and a DNA-based vaccine revs up the immune system to fight the human immunodeficiency virus (HIV), according to a team of researchers from the University of Adelaide in South Australia.

Researchers from the University of Louisville School of Public Health and Information Sciences in Kentucky examined one factor that could affect the disparity – drug policies.

The broadly neutralizing antibody VRC01 slowed down plasma viral rebound in patients with human immunodeficiency virus, compared to historical controls, but did not maintain viral suppression.

In a world with iCloud and other storage options, USBs have somewhat taken a back seat. But a new test for the human immunodeficiency virus (HIV) could put them back in the spotlight.

Should porn actors be forced to wear condoms as a public health measure? It's on the ballot in California but both major political parties oppose it.

“November 7, 1991 was a life changing day that I never saw coming,” Earvin “Magic” Johnson wrote on his site, The Playbook.

Researchers offer road map for choosing antiretroviral therapies for treatment-naive HIV patients.

Patients with HIV are three times more likely to smoke cigarettes than the general population, which means that about 40% of people with HIV are smokers.

There is an optimal drug regimen for preventing HIV positive mothers from infecting their newborns. But it comes with more adverse events.

It’s been known that people with HIV have a substantially higher risk of getting certain kinds of cancer, including anal, liver, and lung, as well as Hodgkin lymphoma, according to the National Cancer Institute. As of November 3, HIV is officially considered a carcinogen.

Before antibiotics, people went blind from syphilis. They still could, the US Centers for Disease Control and Prevention warned today.

Researchers from the University of Georgia have created a mathematical model in hopes of finding the point at which infectious diseases like Zika explode from an isolated murmur into an outbreak roar.

Patients with HIV are likely to have other sexually transmitted infections, but routine testing may be too expensive an urban Alabama clinic estimated.

Concerns that high-risk men on pre-exposure prophylaxis (PrEP) for HIV would stop using condoms and start getting other sexually transmitted infections have been somewhat validated in a Boston clinic.

Transmitted HIV drug resistance is a growing problem. Researchers found 20% of treat-naive HIV patients in a rural Southern US community had such transmitted drug resistant strains of the virus.

A new drug combo had good results in treatment-naïve women with HIV, researchers reported today at IDWeek 2016 in New Orleans, LA.

An experimental biologic for treating drug-resistant HIV showed dramatic results in phase 3 trials, researchers report. It's called ibalizumab.

“We have reached a decisive moment for the nation,” said Jonathan Mermin, MD, MPH, director of the CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.